2156.2000 71.70 (3.44%)
NSE Aug 28, 2025 15:31 PM
Volume: 158.5K
 

2156.20
3.44%
ICICI Securities Limited
The Q3FY21 operational performance was mostly in line with our expectations whereas profitability was below due to lower than expected other income. Revenues grew 20.2% YoY to | 274 crore. EBITDA margins improved 89 bps YoY to 30.6% due to higher gross margins, lower other expenses partly offset by higher staff costs likely due to acquired subsidiaries. Hence, EBITDA grew 23.9% YoY to | 84 crore. However, PAT...
Caplin Point Laboratories Ltd. is trading above all available SMAs
More from Caplin Point Laboratories Ltd.
Recommended